Avacta cancer drug candidate AVA6000 advances to fourth dose cohort
(Alliance News) - Avacta Group PLC said on Wednesday its candidate for multiple forms of cancer, AVA6000 Pro-doxorubicin, is advancing to its fourth dose cohort.
Read moreMon, 01st Aug 2016 14:16
(Alliance News) - Avacta Group PLC said on Wednesday its candidate for multiple forms of cancer, AVA6000 Pro-doxorubicin, is advancing to its fourth dose cohort.
Read more(Sharecast News) - Clinical-stage biopharmaceutical company Avacta Group announced on Thursday that AffyXell, its joint venture with Daewoong Pharmaceuticals, has completed a funding round to advance its lead mesenchymal stem cell (MSC) programme towards the clinic, and to develop its wider preclinical pipeline of cell therapies.
Read more(Alliance News) - Avacta Group PLC on Thursday said that its joint venture AffyXell with Daewoong Pharmaceuticals Co Ltd has successfully completed a funding round.
Read more(Alliance News) - Avacta Group PLC said on Thursday that LG Chem Life Sciences has exercised its renewal option as part of an ongoing collaboration with the company, triggering a fee payment of USD2 million to Avacta.
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.
Read more(Alliance News) - Avacta Group PLC said on Wednesday its candidate for multiple forms of cancer, AVA6000 Pro-doxorubicin, is advancing to its third dose cohort after "a positive review of the safety data" from the second cohort.
Read moreFriday 17 June | |
Blackstone Loan Financing Ltd | AGM |
boohoo Group PLC | AGM |
Directa Plus PLC | AGM |
Tesco PLC | AGM |
EnQuest PLC | AGM |
Octopus Renewables Infrastructure Trust PLC | AGM |
Monday 20 June | |
Armadale Capital PLC | AGM |
Bank of Georgia Group PLC | AGM |
Globalworth Real Estate Investments Ltd | AGM |
MetalNRG PLC | AGM |
Midatech Pharma PLC | AGM |
Silver Bullet Data Services Group PLC | GM re fundraise |
Venture Life Group PLC | AGM |
Tuesday 21 June | |
1Spatial PLC | AGM |
Altus Strategies PLC | AGM |
Coca-Cola HBC AG | AGM |
FireAngel Safety Technology Group PLC | AGM |
HC Slingsby PLC | AGM |
HSS Hire Group PLC | AGM |
Mission Group PLC | AGM |
Novacyt SA | AGM |
Pendragon PLC | AGM |
RTW Venture Fund Ltd | AGM |
Velocys PLC | AGM |
Wednesday 22 June | |
ASA International Group PLC | AGM |
Atalaya Mining PLC | AGM |
Bonhill Group PLC | AGM |
Chapel Down Group PLC | AGM |
Churchill China PLC | AGM |
Downing Renewables & Infrastructure Trust PLC | GM re share issue |
Ecofin US Renewables Infrastructure Trust PLC | AGM |
EJF Investments Ltd | AGM |
Frenkel Topping Group PLC | AGM |
Good Energy Group PLC | AGM |
Honeycomb Investment Trust PLC | AGM |
ICG-Longbow Senior Secured UK Property Debt Investments Ltd | AGM |
Intelligent Ultrasound Group PLC | AGM |
Iofina PLC | AGM |
John Wood Group PLC | AGM |
Kingfisher PLC | AGM |
LXi REIT PLC | GM |
Menhaden PLC | AGM |
North Atlantic Smaller Cos Investment Trust PLC | AGM |
Pennant International Group PLC | AGM |
Plant Health Care PLC | AGM |
Skillcast Group PLC | AGM |
Team PLC | AGM |
Tribal Group PLC | GM re final dividend |
Trident Royalties PLC | AGM |
Vertu Motors PLC | AGM |
Wentworth Resources PLC | AGM |
Thursday 23 June | |
Avacta Group PLC | AGM |
Anglo Asian Mining PLC | AGM |
Card Factory PLC | AGM |
Cordiant Digital Infrastructure Ltd | AGM |
Downing Renewables & Infrastructure Trust PLC | GM re initial placing & open offer |
Eight Capital Partners PLC | GM re aligning 2022 bonds with 2026 bonds |
GENinCode PLC | AGM |
Ideagen PLC | GM re takeover by Hg Pooled Management Ltd |
Longboat Energy PLC | AGM |
Oxford Nanopore Technologies PLC | AGM |
Puma VCT 13 PLC | GM re cancellation of listing & liquidation |
RBG Holdings PLC | AGM |
Tandem Group PLC | AGM |
Zinnwald Lithium PLC | AGM |
Copyright 2022 Alliance News Limited. All Rights Reserved. |
Avacta Group PLC - Cambridge, England-based drug developer and diagnostics company - Says its joint venture AffyXell with Seoul, South Korea-based drug maker Daewoong Pharmaceutical Co Ltd expanded its partnership with GenScript ProBio. Says the partnership covers the process development and production of viral vectors required for the production of AffyXell's future cell therapy products. Adds that GenScript has now committed to take an equity position in AffyXell at a future funding round. The two companies will also collaborate in the area of business development, including potential out-licensing.
Read more(Alliance News) - Avacta Group PLC said on Wednesday it increased its shareholding in its South Korean joint venture, AffyXell Therapeutics.
Read more(Sharecast News) - Clinical-stage oncology drug company Avacta announced on Wednesday that a milestone equity payment has been triggered, resulting in an increase in its shareholding in AffyXell Therapeutics.
Read more(Sharecast News) - Clinical-stage oncology drug company Avacta announced on Friday that AffyXell Therapeutics - its joint venture with Daewoong Pharmaceutical - has entered into a collaboration agreement with Chinese biological drugs developer Biocytogen and the Korea Non-Clinical Technology Solution Center (KNTSC).
Read more(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
Read more(Alliance News) - Avacta Group PLC said on Friday its joint venture has found a Chinese collaborator to develop new biologic drugs.
Read moreAvacta Group PLC - Cambridge, England-based drug developer and diagnostics company - Posts widened loss in 2021. Pretax loss expands to GBP29.2 million from GBP18.9 million in 2020. However, revenue rises to GBP2.9 million from GBP2.1 million. Like the year before, there will be no dividends.
Read more(Sharecast News) - Clinical-stage oncology drug company Avacta Group announced on Wednesday that Vimian Group has acquired its veterinary division, Avacta Animal Health, for consideration of up to £2.3m.
Read more